1. Home
  2. AVDL vs UVSP Comparison

AVDL vs UVSP Comparison

Compare AVDL & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • UVSP
  • Stock Information
  • Founded
  • AVDL 2015
  • UVSP 1876
  • Country
  • AVDL Ireland
  • UVSP United States
  • Employees
  • AVDL N/A
  • UVSP N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • UVSP Major Banks
  • Sector
  • AVDL Health Care
  • UVSP Finance
  • Exchange
  • AVDL Nasdaq
  • UVSP Nasdaq
  • Market Cap
  • AVDL 786.3M
  • UVSP 855.6M
  • IPO Year
  • AVDL 1996
  • UVSP 1989
  • Fundamental
  • Price
  • AVDL $7.64
  • UVSP $30.39
  • Analyst Decision
  • AVDL Strong Buy
  • UVSP Hold
  • Analyst Count
  • AVDL 6
  • UVSP 3
  • Target Price
  • AVDL $20.00
  • UVSP $29.00
  • AVG Volume (30 Days)
  • AVDL 1.7M
  • UVSP 91.0K
  • Earning Date
  • AVDL 03-03-2025
  • UVSP 01-22-2025
  • Dividend Yield
  • AVDL N/A
  • UVSP 2.77%
  • EPS Growth
  • AVDL N/A
  • UVSP 7.05
  • EPS
  • AVDL N/A
  • UVSP 2.58
  • Revenue
  • AVDL $138,160,000.00
  • UVSP $293,292,000.00
  • Revenue This Year
  • AVDL $515.63
  • UVSP N/A
  • Revenue Next Year
  • AVDL $49.32
  • UVSP $7.52
  • P/E Ratio
  • AVDL N/A
  • UVSP $11.85
  • Revenue Growth
  • AVDL 1523.50
  • UVSP 2.53
  • 52 Week Low
  • AVDL $7.39
  • UVSP $18.41
  • 52 Week High
  • AVDL $19.09
  • UVSP $32.75
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 30.42
  • UVSP 55.90
  • Support Level
  • AVDL $7.40
  • UVSP $28.82
  • Resistance Level
  • AVDL $8.01
  • UVSP $31.05
  • Average True Range (ATR)
  • AVDL 0.44
  • UVSP 0.85
  • MACD
  • AVDL -0.07
  • UVSP 0.22
  • Stochastic Oscillator
  • AVDL 6.93
  • UVSP 83.25

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: